Panagora Asset Management Inc Natera, Inc. Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$30.32 - $91.33 $371,935 - $1.12 Million	-12,267 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$86.26 - $119.0 $1,552 - $2,142	-18 Reduced 0.15%	12,267 $1.15 Million
Q2 2021 Aug 11, 2021	SELL	$86.05 - $119.72 $8.5 Million - $11.8 Million	-98,809 Reduced 88.94%	12,285 $1.4 Million
Q1 2021 May 12, 2021	BUY	$91.47 - $124.36 $8.46 Million - $11.5 Million	92,537 Added 498.66%	111,094 $11.3 Million
Q4 2020 Feb 10, 2021	BUY	$66.66 - $111.74 $1.24 Million - $2.07 Million	18,557 New	18,557 $1.85 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.